Alpha Tau Medical R&D Spending Growth & History (DRTS)
Alpha Tau Medical's r&d spending was $32.1M for fiscal 2025.
View full Alpha Tau Medical company overviewAlpha Tau Medical annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $32.1M | $5.0M | +18.67% |
| 2024 | 2024-12-31 | $27.0M | $596,000 | +2.26% |
| 2023 | 2023-12-31 | $26.4M | $5.5M | +26.49% |
| 2022 | 2022-12-31 | $20.9M | $9.4M | +82.49% |
| 2021 | 2021-12-31 | $11.4M | $3.9M | +51.74% |
| 2020 | 2020-12-31 | $7.5M | $908,000 | +13.68% |
| 2019 | 2019-12-31 | $6.6M | — | — |
Alpha Tau Medical quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $9.9M | $2.9M | +41.29% |
| Q1 2026 | 2026-03-31 | $11.0M | $3.8M | +53.07% |
| Q4 2025 | 2025-12-31 | $9.6M | — | — |
| Q3 2025 | 2025-09-30 | $8.3M | — | — |
| Q2 2025 | 2025-06-30 | $7.0M | — | — |
| Q1 2025 | 2025-03-31 | $7.2M | — | — |
Alpha Tau Medical r&d spending trends
Over the last five fiscal years, Alpha Tau Medical's r&d spending increased from $7.5M to $32.1M, a change of $24.5M. The latest reported quarter, Q2 2026, shows $9.9M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alpha Tau Medical source filings ↗